@article{3164209,
    title = "Surgery for liver metastases from breast cancer",
    author = "Charalampoudis, Petros and Mantas, Dimitrios and Sotiropoulos, Georgios and C. and Dimitroulis, Dimitrios and Kouraklis, Gregory and Markopoulos, and Christos",
    journal = "Future oncology (London, England)",
    year = "2015",
    volume = "11",
    number = "10",
    pages = "1519-1530",
    publisher = "Future Medicine Ltd",
    doi = "10.2217/fon.15.43",
    keywords = "breast cancer; chemotherapy; hepatectomy; liver metastases;
metastasectomy; resection; survival; surgery",
    abstract = "Introduction: Liver metastases from breast cancer (BCLM) confer poor
survival. Liver resection in BCLM patients has been increasingly
employed. Aim: We undertook a systematic review to evaluate the role of
hepatic resection in patients with breast cancer metastatic to the
liver. Materials & methods: In total, 36 studies were overviewed.
Patient populations, characteristics, morbidity, mortality and survival
were documented. Results: Median overall survival was 41 months. Major
morbidity was rare while 30-day postoperative mortality was near nil.
Conclusion: Liver surgery for BCLM can be performed with low mortality,
acceptable morbidity and promising survival benefit in carefully
selected patients."
}